Mukdahan International Hospital PCL (BKK:HANN)
Thailand
· Delayed Price · Currency is THB 0.920
-0.010 (-1.08%)
At close: Apr 28, 2026
BKK:HANN Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 463.06 | 492.5 | 527.06 | 487.92 | 511.88 |
| Revenue Growth (YoY) | -5.98% | -6.56% | 8.02% | -4.68% | - |
| Cost of Revenue | 335.06 | 342.4 | 369.98 | 369.67 | 335.87 |
| Gross Profit | 128 | 150.1 | 157.08 | 118.25 | 176.02 |
| Selling, General & Admin | 116.75 | 123.1 | 114.03 | 96.71 | 75.55 |
| Operating Expenses | 116.75 | 123.1 | 114.03 | 96.71 | 75.55 |
| Operating Income | 11.25 | 27 | 43.06 | 21.54 | 100.47 |
| Interest Expense | -3.14 | -3.86 | -7.04 | -5.22 | -6.55 |
| Interest & Investment Income | 0.16 | 0.14 | 0.22 | 0.06 | 0.02 |
| Currency Exchange Gain (Loss) | 2.83 | 0.05 | -0.14 | 0.02 | 0.07 |
| Other Non Operating Income (Expenses) | 3.54 | 3.73 | 4.31 | 8.98 | 5.26 |
| EBT Excluding Unusual Items | 14.63 | 27.07 | 40.4 | 25.37 | 99.26 |
| Gain (Loss) on Sale of Assets | -0.04 | -0.09 | 0.5 | -0.04 | -0.22 |
| Asset Writedown | -0.21 | -0.12 | -3.6 | - | - |
| Other Unusual Items | 0.06 | - | 2.14 | - | - |
| Pretax Income | 14.44 | 26.85 | 39.45 | 25.33 | 99.04 |
| Income Tax Expense | -7.52 | 5.67 | 11.67 | 5.74 | 19.73 |
| Earnings From Continuing Operations | 21.96 | 21.18 | 27.77 | 19.59 | 79.31 |
| Minority Interest in Earnings | -0 | -0 | -0 | -22.3 | -82.74 |
| Net Income | 21.96 | 21.18 | 27.77 | -2.71 | -3.43 |
| Net Income to Common | 21.96 | 21.18 | 27.77 | -2.71 | -3.43 |
| Net Income Growth | 3.68% | -23.72% | - | - | - |
| Shares Outstanding (Basic) | 467 | 400 | 400 | 205 | 200 |
| Shares Outstanding (Diluted) | 467 | 400 | 400 | 205 | 200 |
| Shares Change (YoY) | 16.77% | - | 95.19% | 2.47% | - |
| EPS (Basic) | 0.05 | 0.05 | 0.07 | -0.01 | -0.02 |
| EPS (Diluted) | 0.05 | 0.05 | 0.07 | -0.01 | -0.02 |
| EPS Growth | -11.21% | -23.72% | - | - | - |
| Free Cash Flow | 39.21 | 8.05 | 81.85 | 25.51 | 69.53 |
| Free Cash Flow Per Share | 0.08 | 0.02 | 0.20 | 0.12 | 0.35 |
| Dividend Per Share | 0.036 | 0.004 | 0.085 | - | - |
| Dividend Growth | 942.86% | -95.88% | - | - | - |
| Gross Margin | 27.64% | 30.48% | 29.80% | 24.23% | 34.39% |
| Operating Margin | 2.43% | 5.48% | 8.17% | 4.41% | 19.63% |
| Profit Margin | 4.74% | 4.30% | 5.27% | -0.56% | -0.67% |
| Free Cash Flow Margin | 8.47% | 1.64% | 15.53% | 5.23% | 13.58% |
| EBITDA | 42.7 | 57.7 | 76.66 | 52.84 | 135.2 |
| EBITDA Margin | 9.22% | 11.72% | 14.54% | 10.83% | 26.41% |
| D&A For EBITDA | 31.45 | 30.7 | 33.6 | 31.3 | 34.74 |
| EBIT | 11.25 | 27 | 43.06 | 21.54 | 100.47 |
| EBIT Margin | 2.43% | 5.48% | 8.17% | 4.41% | 19.63% |
| Effective Tax Rate | - | 21.12% | 29.60% | 22.65% | 19.92% |
| Advertising Expenses | - | - | - | 2.18 | 1.59 |
Source: S&P Capital IQ. Standard template. Financial Sources.